Develops a reliable method for assessing drug quality in tablet form, suggesting improvements in analytical practices.
This research develops and validates a stability-indicating assay method for anti-Parkinson drugs in tablet form using reverse-phase HPLC. The objective is to create accurate, cost-effective analytical methods for API quantification through RP-HPLC and UV techniques. The approach involves standard and sample solution preparation, along with buffer formulation. Results show direct proportionality between analyte concentration and obtained areas, establishing linearity. The method demonstrates a suitable range, accurate recovery rates meeting acceptance criteria, precise results within limits, and robustness with no significant system suitability changes. This research provides reliable and economical analytical methods for assessing anti-parkinson drug quality and stability.
No takes yet. Share an insight, caveat, or question.
Jain et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: